The impact of lipocalin-type-prostaglandin-D-synthase as a predictor of kidney disease in patients with type 2 diabetes
Marcelo Rodrigues Bacci1, Marina Romera Cavallari1, Ross Martin de Rozier-Alves2, Beatriz da Costa Aguiar Alves2, Fernando Luiz Affonso Fonseca2,31General Practice Department, 2Clinical Analysis Laboratory, ABC Medical School, 3Biological Sciences Department, Federal University of São Pau...
Saved in:
Main Authors: | Bacci MR (Author), Cavallari MR (Author), de Rozier-Alves RM (Author), Alves BCA (Author), Fonseca FLA (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Microsomal prostaglandin E synthase-1 in rheumatic diseases
by: Marina eKorotkova, et al.
Published: (2011) -
Cycle Network Model of Prostaglandin H Synthase-1
by: Alexey Goltsov, et al.
Published: (2020) -
Hematopoietic-Prostaglandin D2 synthase through PGD2 production is involved in the adult ovarian physiology
by: Farhat Andalib, et al.
Published: (2011) -
Neutrophil Gelatinase-Associated Lipocalin and Kidney Diseases
by: Hyung Eun Yim
Published: (2015) -
Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV)
by: Navari RM
Published: (2014)